Literature DB >> 11257207

Extracting functional information from tissues.

M P DiGiovanna1.   

Abstract

Mesh：

Substances：

Year:  2001        PMID： 11257207     DOI： 10.1007/bf03262099

Source DB:  PubMed          Journal:  Mol Diagn        ISSN： 1084-8592


× No keyword cloud information.
  12 in total

1.  Detection of ErbB2 oversignalling in a majority of breast cancers with phosphorylation-state-specific antibodies.

Authors:  X Ouyang; T Gulliford; A Doherty; G C Huang; R J Epstein
Journal:  Lancet       Date:  1999-05-08       Impact factor: 79.321

2.  Synthetic phosphopeptide immunogens yield activation-specific antibodies to the c-erbB-2 receptor.

Authors:  R J Epstein; B J Druker; T M Roberts; C D Stiles
Journal:  Proc Natl Acad Sci U S A       Date:  1992-11-01       Impact factor: 11.205

3.  The subcellular localization of the neu protein in human normal and neoplastic cells.

Authors:  C R De Potter; J Quatacker; G Maertens; S Van Daele; C Pauwels; C Verhofstede; W Eechaute; H Roels
Journal:  Int J Cancer       Date:  1989-12-15       Impact factor: 7.396

4.  The expression of the neu oncogene product in breast lesions and in normal fetal and adult human tissues.

Authors:  C R De Potter; S Van Daele; M J Van de Vijver; C Pauwels; G Maertens; J De Boever; D Vandekerckhove; H Roels
Journal:  Histopathology       Date:  1989-10       Impact factor: 5.087

5.  Multisite phosphotyping of the ErbB-2 oncoprotein in human breast cancer.

Authors:  X Ouyang; T Gulliford; G C Huang; C Harper-Wynne; S Shousha; R J Epstein
Journal:  Mol Diagn       Date:  2001-03

6.  Activation (tyrosine phosphorylation) of ErbB-2 (HER-2/neu): a study of incidence and correlation with outcome in breast cancer.

Authors:  A D Thor; S Liu; S Edgerton; D Moore; K M Kasowitz; C C Benz; D F Stern; M P DiGiovanna
Journal:  J Clin Oncol       Date:  2000-09-15       Impact factor: 44.544

7.  Tumor-inhibitory antibodies to HER-2/ErbB-2 may act by recruiting c-Cbl and enhancing ubiquitination of HER-2.

Authors:  L N Klapper; H Waterman; M Sela; Y Yarden
Journal:  Cancer Res       Date:  2000-07-01       Impact factor: 12.701

Review 8.  Prognostic factors in breast cancer. College of American Pathologists Consensus Statement 1999.

Authors:  P L Fitzgibbons; D L Page; D Weaver; A D Thor; D C Allred; G M Clark; S G Ruby; F O'Malley; J F Simpson; J L Connolly; D F Hayes; S B Edge; A Lichter; S J Schnitt
Journal:  Arch Pathol Lab Med       Date:  2000-07       Impact factor: 5.534

9.  Surface expression of erbB-2 protein is post-transcriptionally regulated in mammary epithelial cells by epidermal growth factor and by the culture density.

Authors:  E S Kornilova; D Taverna; W Hoeck; N E Hynes
Journal:  Oncogene       Date:  1992-03       Impact factor: 9.867

10.  Functional assay for HER-2/neu demonstrates active signalling in a minority of HER-2/neu-overexpressing invasive human breast tumours.

Authors:  M P DiGiovanna; D Carter; S D Flynn; D F Stern
Journal:  Br J Cancer       Date:  1996-09       Impact factor: 7.640
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.